Antiemetics And Antinauseants Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

Which drivers are expected to have the greatest impact on the over the antiemetics and antinauseants market's growth?
The market for antiemetics and antinauseants is propelled by the rising incidence of cancer. Chemotherapy, considered one of the key cancer treatments, can cause side effects like chemotherapy-induced nausea and vomiting (CINV). Approximately 60%-70% of patients can prevent CINV using antiemetics. For example, The American Cancer Society, a US-based non-profit organization, estimated in April 2024 that there were approximately 609,000 cancer-related fatalities and expected 1.9 million new cancer diagnoses in the US in 2022. They anticipate about 620,000 cancer deaths, showing a slight increase in death rates by 2024. A surge in cancer incidences will enhance the demand for antiemetics and antinauseants, boosting the market's revenue.

Get Your Antiemetics And Antinauseants Market Report Here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What is the future CAGR of the antiemetics and antinauseants market, and how will it impact industry expansion?
In recent times, the market for antiemetics and antinauseants has been on a consistent growth trajectory. The market is projected to escalate from a value of $8.11 billion in 2024 to $8.45 billion in 2025, representing a compound annual growth rate (CAGR) of 4.3%. Factors contributing to this growth during the historical period include historical branding efforts, competitive market conditions, past treatment preferences, economic circumstances, global health incidents in the past, and advancements in medical research and technology.

The market for antiemetics and antinauseants is projected to experience substantial expansion in the approaching years, reaching a value of $9.7 billion in 2029 with a compound annual growth rate (CAGR) of 3.5%. This predicted growth during the forecast period can be tied to several factors such as research and development efforts, economic conditions, market competition, industry trends, shifts in disease patterns, and healthcare policies and regulations. Key trends projected for this period are an intensified focus on patient experience, evolving healthcare policies, a consumer lean towards non-invasive procedures, an increasing incidence of nausea related to chemotherapy and pregnancy, and the rise of targeted therapies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What new trends are reshaping the antiemetics and antinauseants market and its opportunities?
Significant players in the antiemetic and antinauseant markets are focusing on innovative product development, such as pre-prepared injectables, to improve treatment protocols and boost patient adherence. These pre-prepared solutions aim to offer immediate relief, lessening the intricacy and duration involved in conventional injection medications. For instance, in July 2024, Amneal Pharmaceuticals, a specialty pharmaceutical enterprise based in the US, introduced FOCINVEZ, the inaugural pre-prepared injectable formulation of fosaprepitant, created to combat acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product, offered in a 150 mg/50 mL vial without Polysorbate 80, bypasses the need for reconstitution or dilution, enabling straightforward administration. FOCINVEZ has been approved for adults and pediatric patients aged six months and above, receiving a unique J-Code (J1434) for reimbursement purposes.

Which key market segments comprise the antiemetics and antinauseants market and drive its revenue growth?
The antiemetics and antinauseants market covered in this report is segmented -

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), cannabinoi*ds, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By cannabinoi*ds: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

What regions are at the forefront of antiemetics and antinauseants market expansion?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the antiemetics and antinauseants market?
Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Is Covered In The Antiemetics And Antinauseants Global Market Report?

• Market Size Forecast: Examine the antiemetics and antinauseants market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the antiemetics and antinauseants market for a structured understanding.
• Key Players Overview: Analyze major players in the antiemetics and antinauseants market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the antiemetics and antinauseants market.
• Segment Contributions: Evaluate how different segments drive overall growth in the antiemetics and antinauseants market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the antiemetics and antinauseants market.
• Industry Challenges: Identify potential risks and obstacles affecting the antiemetics and antinauseants market.
• Competitive Landscape: Review strategic developments in the antiemetics and antinauseants market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.